Absci on Wednesday disclosed what it called positive data from an ongoing, early-stage trial of its investigational treatment for hair loss. The biopharmaceutical company, which uses generative ...
Stocks are rising on Wall Street as falling bond yields and lower oil prices help ease pressure on the market. The S&P 500 ...
InvestorsHub on MSN
Absci shares soar after positive early clinical results for hair loss therapy (ABSI)
Absci Corporation (NASDAQ:ABSI) shares surged 24% on Wednesday after the biotechnology company reported encouraging interim ...
No news for REGS in the past two years. The total number of shares of a security that have been sold short and not yet repurchased. Change from Last Percentage change in short interest from the ...
Stocktwits on MSN
ABSI stock eyes best day ever after positive hair loss drug data, $100M Lilly-backed raise
The study has now moved into testing in people who actually have pattern hair loss. ・Absci expects initial proof-of-concept data from this stage in the second half of 2026, with more complete results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results